CoSara Diagnostics has secured clearance from the Indian Central Drugs Standard Control Organization (CDSCO) to manufacture and sell its Saragene COVID-19 2-gene multiplex RT-PCR test. The approval allows the Saragene COVID-19 2-gene multiplex RT-PCR test to be used as an in vitro diagnostic (IVD) in the qualitative detection of the SARS-CoV-2 virus that causes Covid-19. […]
Continue reading …Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]
Continue reading …Teleflex, a Pennsylvania-based healthcare supplies and services provider, has agreed to acquire hemostatic devices manufacturer Z-Medica, in a deal worth up to $525 million. Based in Connecticut, Z-Medica is a portfolio company of Linden Capital Partners. The company is engaged in developing and commercializing hemorrhage control products. Its three main hemostatic device brands are QuikClot, […]
Continue reading …Exact Sciences, a US molecular diagnostics company, has agreed to acquire Thrive Earlier Detection in a cash cum stock deal worth up to $2.15 billion, in a move to become a leading player in blood-based, multi-cancer screening. Based in Cambridge and Baltimore, Thrive Earlier Detection is a healthcare company focused on incorporating earlier cancer detection […]
Continue reading …Paramit, a US-based manufacturer of medical devices and life science instruments, has signed a deal to acquire Austria-based S.I.E. SOLUTIONS, as part of a strategic expansion into Europe. The financial terms of the deal were not disclosed. S.I.E SOLUTIONS is engaged in providing embedded technology solutions to customers across the healthcare and security technology sectors. […]
Continue reading …Bracco Diagnostics, the US subsidiary of Italian diagnostic imaging company Bracco Imaging, has secured approval from the US Food and Drug Administration (FDA) for its new CardioGen-82 infusion system. According to Bracco Diagnostics, CardioGen-82 infusion system is used for improving automation, efficiency, and simplicity in cardiac position emission tomography (PET) myocardial perfusion imaging (MPI). CARDIOGEN-82 […]
Continue reading …Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and identify viruses within five minutes, said the UK-based university. The method can be used to differentiate the SARS-CoV-2 virus from negative clinical samples and also from other common respiratory pathogens […]
Continue reading …R3 Vascular, an early-stage US medical device company, has raised $17.8 million in a Series A financing round, led by an undisclosed corporate investor and 415 CAPITAL. The funding comprised new equity investments of $15 million and the conversion of $2.8 million of convertible notes. The Series A round also saw participation from HBM-MedFocus and Wexford […]
Continue reading …